Author details

Full Name

Roisin Worsley

Affiliation

ORCID

Career Start Year

2012

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36758325	The use of first and second-generation antipsychotic drugs and the potential to develop gestational diabetes mellitus among perinatal patients with psychosis.		2023
37624837	Correction: A Prospective Cohort Study of Antipsychotic Medications in Pregnancy: The First 147 Pregnancies and 100 One Year Old Babies.		2023
32218215	Effects of Oral Contraceptive Androgenicity on Visuospatial and Social-Emotional Cognition: A Prospective Observational Trial.	Brain Sciences	2020
31126870	The influence of endogenous estrogen on high-frequency prefrontal transcranial magnetic stimulation.	Brain Stimulation	2019
30299258	Raloxifene as a treatment for cognition in women with schizophrenia: the influence of menopause status.	Psychoneuroendocrinology	2019
29723767	Tibolone improves depression in women through the menopause transition: A double-blind randomized controlled trial of adjunctive tibolone.	Journal of Affective Disorders	2018
30358730	Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years.	Menopause	2018
29980009	Menstrual cycle irregularity and menopause status influence cognition in women with schizophrenia.	Psychoneuroendocrinology	2018
29955034	Development and validation of a new rating scale for perimenopausal depression-the Meno-D.	Translational Psychiatry	2018
30044024	The influence of endogenous estrogen on transcranial direct current stimulation: A preliminary study.	European Journal of Neuroscience	2018
27916394	Hypoactive Sexual Desire Disorder: International Society for the Study of Women's Sexual Health (ISSWSH) Expert Consensus Panel Review.	Mayo Clinic Proceedings	2017
28499520	Prevalence and Predictors of Low Sexual Desire, Sexually Related Personal Distress, and Hypoactive Sexual Desire Dysfunction in a Community-Based Sample of Midlife Women.	J Sex Med	2017
28889207	Antipsychotic-induced hyperprolactinemia: synthesis of world-wide guidelines and integrated recommendations for assessment, management and future research.	Psychopharmacology	2017
28263691	Moderate-Severe Vasomotor Symptoms Are Associated with Moderate-Severe Depressive Symptoms.	J Womens Health (Larchmt)	2017
27687775	Raloxifene for schizophrenia and symptoms of hyperprolactinaemia?	Australian and New Zealand Journal of Psychiatry	2017
27510353	Lessons from the bedside: ketoacidosis and SGLT2 inhibitors.	Medical Journal of Australia	2016
27438995	Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women: A Randomized Clinical Trial.	JAMA Psychiatry	2016
27013286	Menopausal vasomotor symptoms are associated with poor self-assessed work ability.	Maturitas	2016
26953831	Androgens and Female Sexual Function and Dysfunction--Findings From the Fourth International Consultation of Sexual Medicine.	J Sex Med	2016
26944462	Role of Estrogens and Estrogen-Like Compounds in Female Sexual Function and Dysfunction.	J Sex Med	2016
26944460	Hormones and Female Sexual Dysfunction: Beyond Estrogens and Androgens--Findings from the Fourth International Consultation on Sexual Medicine.	J Sex Med	2016
26553218	Borderline personality disorder and polycystic ovary syndrome.	Australian and New Zealand Journal of Psychiatry	2016
26070315	Menstrual cycle characteristics in women with persistent schizophrenia.	Australian and New Zealand Journal of Psychiatry	2016
26240945	Low use of effective and safe therapies for moderate to severe menopausal symptoms: a cross-sectional community study of Australian women.	Menopause	2016
24732671	Estradiol for treatment-resistant schizophrenia: a large-scale randomized-controlled trial in women of child-bearing age.	Molecular Psychiatry	2015
25333776	Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.	Climacteric	2015
25706184	Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years.	Menopause	2015
26224187	Use of complementary and alternative medicines for menopausal symptoms in Australian women aged 40-65 years.	Med J Aust	2015
26001182	Antipsychotic use in pregnancy.	Expert Opinion on Pharmacotherapy	2015
26115590	Moderate-severely bothersome vasomotor symptoms are associated with lowered psychological general wellbeing in women at midlife.	Maturitas	2015
24787688	A prospective cohort study of antipsychotic medications in pregnancy: the first 147 pregnancies and 100 one year old babies.	PLoS ONE	2014
25358653	Establishing female-only areas in psychiatry wards to improve safety and quality of care for women.	Australasian Psychiatry	2014
24365649	The association between vasomotor symptoms and depression during perimenopause: a systematic review.	Maturitas	2014
24651061	Gestational diabetes in women with mental illness.	Australian and New Zealand Journal of Psychiatry	2014
24703170	A four week randomised control trial of adjunctive medroxyprogesterone and tamoxifen in women with mania.	Psychoneuroendocrinology	2014
24716847	Transdermal testosterone improves verbal learning and memory in postmenopausal women not on oestrogen therapy.	Clin Endocrinol (Oxf)	2014
24856205	A systematic review of the impact of oral contraceptives on cognition.		2014
23727129	Androgen treatment of postmenopausal women.	J Steroid Biochem Mol Biol	2014
23499040	Breastfeeding and psychotropic medications.	Lancet, The	2013
24348584	The role of estrogen in the treatment of men with schizophrenia.	International Journal of Endocrinology and Metabolism	2013
24237092	Psychotropic medication in pregnancy.	Medical Journal of Australia	2013
23531683	Endogenous estrogen and androgen levels are not independent predictors of lipid levels in postmenopausal women.	Menopause	2013
23212139	Female sexual dysfunction in psychiatry.	Australian and New Zealand Journal of Psychiatry	2012
23843841	Raloxifene may have further benefits in women on hemodialysis.	International Journal of Endocrinology and Metabolism	2012
22824374	Hormonal therapies for new onset and relapsed depression during perimenopause.	Maturitas	2012
22626057	Role of estrogen treatment in the management of schizophrenia.	CNS Drugs	2012
22853790	Special biological issues in the management of women with schizophrenia.	Expert Review of Neurotherapeutics	2012